E-MTAB-3606 - Screening of rheumatoid arthritis patients sera against citrullinated fibrinogen peptides using ImmunoCAP ISAC system

Status
Submitted on 7 October 2014, released on 25 October 2015, last updated on 22 February 2016
Organism
Homo sapiens
Samples (1388)
Array (1)
Protocols (8)
Description
Citrullinated and unmodified peptides (>95% purity, ProImmune AB) were immobilized onto a chemically modified glass slide, sera from RA patients and healthy controls were applied into the reactions sites and fluorescence intensity after incubation with anti-human IgG antibody was acquired in a laser scanner. Final results for each citrullinated peptide were calculated by subtracting the intensity values of corresponding arginine containing control peptide from citrullinated peptide for all RA patients and controls.
Experiment types
antigen profiling, case control design
Contact
MIAME
PlatformsProtocolsVariablesProcessedRaw
Files
Investigation descriptionE-MTAB-3606.idf.txt
Sample and data relationshipE-MTAB-3606.sdrf.txt
Processed data (1)E-MTAB-3606.processed.1.zip
Array designA-MTAB-563.adf.txt
Links